Corrigendum to “Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage ovarian cancer: A retrospective cohort study” [Eur J Cancer 222 (2025) 115472]

Steventon, L., Nicum, S., Chambers, P. et al. (6 more authors) (2025) Corrigendum to “Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage ovarian cancer: A retrospective cohort study” [Eur J Cancer 222 (2025) 115472]. European Journal of Cancer, 223. 115492. ISSN 0959-8049

Metadata

Item Type: Article
Authors/Creators:
Commentary on: Steventon, L., Nicum, S., Chambers, P. et al. (6 more authors) (2025) Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage recurrent ovarian cancer: A retrospective cohort study in England. European Journal of Cancer, 222. 115472. ISSN 0959-8049
Copyright, Publisher and Additional Information:

© 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
Dates:
  • Published (online): 16 May 2025
  • Published: 18 June 2025
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 06 Jun 2025 10:03
Last Modified: 06 Jun 2025 10:07
Published Version: https://www.sciencedirect.com/science/article/pii/...
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.ejca.2025.115492
Related URLs:
Open Archives Initiative ID (OAI ID):

Commentary/Response Threads

Export

Statistics


CORE (COnnecting REpositories)